Literature DB >> 33821345

Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer.

David W Lim1,2,3, Helene Retrouvey4, Isabel Kerrebijn5, Kate Butler4, Anne C O'Neill4, Tulin D Cil6,7, Toni Zhong4, Stefan O P Hofer4, David R McCready7, Kelly A Metcalfe8,9.   

Abstract

INTRODUCTION: Rates of bilateral mastectomy are rising in women with unilateral, nonhereditary breast cancer. We aim to characterize how psychosocial outcomes evolve after breast cancer surgery. PATIENTS AND METHODS: We performed a prospective cohort study of women with unilateral, sporadic stage 0-III breast cancer at University Health Network in Toronto, Canada between 2014 and 2017. Women completed validated psychosocial questionnaires (BREAST-Q, Impact of Event Scale, Hospital Anxiety & Depression Scale) preoperatively, and at 6 and 12 months following surgery. Change in psychosocial scores was assessed between surgical groups using linear mixed models, controlling for age, stage, and adjuvant treatments. P < .05 were significant.
RESULTS: A total of 475 women underwent unilateral lumpectomy (42.5%), unilateral mastectomy (38.3%), and bilateral mastectomy (19.2%). There was a significant interaction (P < .0001) between procedure and time for breast satisfaction, psychosocial and physical well-being. Women having unilateral lumpectomy had higher breast satisfaction and psychosocial well-being scores at 6 and 12 months after surgery compared with either unilateral or bilateral mastectomy, with no difference between the latter two groups. Physical well-being declined in all groups over time; scores were not better in women having bilateral mastectomy. While sexual well-being scores remained stable in the unilateral lumpectomy group, scores declined similarly in both unilateral and bilateral mastectomy groups over time. Cancer-related distress, anxiety, and depression scores declined significantly after surgery, regardless of surgical procedure (P < .001).
CONCLUSIONS: Psychosocial outcomes are not improved with contralateral prophylactic mastectomy in women with unilateral breast cancer. Our data may inform women considering contralateral prophylactic mastectomy.

Entities:  

Year:  2021        PMID: 33821345     DOI: 10.1245/s10434-021-09928-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  56 in total

Review 1.  Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.

Authors:  Kelly K Hunt; David M Euhus; Judy C Boughey; Anees B Chagpar; Sheldon M Feldman; Nora M Hansen; Swati A Kulkarni; David R McCready; Eleftherios P Mamounas; Lee G Wilke; Kimberly J Van Zee; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-12-08       Impact factor: 5.344

2.  Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

Authors:  Stephanie M Wong; Rachel A Freedman; Yasuaki Sagara; Fatih Aydogan; William T Barry; Mehra Golshan
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

3.  State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.

Authors:  Rebecca Nash; Michael Goodman; Chun Chieh Lin; Rachel A Freedman; Laura S Dominici; Kevin Ward; Ahmedin Jemal
Journal:  JAMA Surg       Date:  2017-07-01       Impact factor: 14.766

4.  Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study.

Authors:  L Findlay-Shirras; I Lima; G Smith; M Clemons; A Arnaout
Journal:  Breast Cancer Res Treat       Date:  2020-10-30       Impact factor: 4.872

5.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

6.  Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  K Metcalfe; S Gershman; H T Lynch; P Ghadirian; N Tung; C Kim-Sing; O I Olopade; S Domchek; J McLennan; A Eisen; W D Foulkes; B Rosen; P Sun; S A Narod
Journal:  Br J Cancer       Date:  2011-04-12       Impact factor: 7.640

Review 7.  Risk-reducing mastectomy for the prevention of primary breast cancer.

Authors:  Nora E Carbine; Liz Lostumbo; Judi Wallace; Henry Ko
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

Review 8.  Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy.

Authors:  Kalatu R Davies; Scott B Cantor; Abenaa M Brewster
Journal:  Int J Womens Health       Date:  2015-02-04

9.  Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.

Authors:  Kelly Metcalfe; Shelley Gershman; Parviz Ghadirian; Henry T Lynch; Carrie Snyder; Nadine Tung; Charmaine Kim-Sing; Andrea Eisen; William D Foulkes; Barry Rosen; Ping Sun; Steven A Narod
Journal:  BMJ       Date:  2014-02-11

10.  Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.

Authors:  Judy C Boughey; Deanna J Attai; Steven L Chen; Hiram S Cody; Jill R Dietz; Sheldon M Feldman; Caprice C Greenberg; Rena B Kass; Jeffrey Landercasper; Valerie Lemaine; Fiona MacNeill; Julie A Margenthaler; David H Song; Alicia C Staley; Lee G Wilke; Shawna C Willey; Katharine A Yao
Journal:  Ann Surg Oncol       Date:  2016-07-28       Impact factor: 5.344

View more
  3 in total

1.  De-escalation in breast cancer surgery.

Authors:  Sarah P Shubeck; Monica Morrow; Lesly A Dossett
Journal:  NPJ Breast Cancer       Date:  2022-02-23

Review 2.  Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery.

Authors:  Francesca Magnoni; Virgilio Sacchini; Paolo Veronesi; Beatrice Bianchi; Elisa Bottazzoli; Valentina Tagliaferri; Erica Mazzotta; Giulia Castelnovo; Giulia Deguidi; Elisabetta Maria Cristina Rossi; Giovanni Corso
Journal:  Cancers (Basel)       Date:  2022-07-01       Impact factor: 6.575

3.  Unveiling beauty: Insight into being tattooed postmastectomy.

Authors:  Victoria Reid-de Jong
Journal:  Nurs Forum       Date:  2022-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.